bristol-myers squibb

bristol-myers squibb

NYSE:BMY

Chart

Detailed Quote

Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Unlike some of its more diversified peers, Bristol has exited several nonpharmaceutical businesses to focus on branded specialty drugs, which tend to support strong pricing power.
Featured Articles and Interviews
Glowing pills hover above a futuristic digital platform with blue light background.

DCVC, NVIDIA Back Proxima’s US$80 Million Bet on AI Drug Discovery

Large pharmaceutical pill with gold dollar sign in the middle. Stock tickers and charts in the background.

Top 5 Small-cap Pharma Stocks (Updated January 2026)

Various colorful pills and tablets scattered from a brown bottle on a blue background.

Pharma Market Forecast: Top Trends for Pharma in 2026

Press Releases

Bristol Myers Squibb to Build the Most Powerful AI Factory in Life Sciences with NVIDIA

U.S. Food and Drug Administration Accepts Bristol Myers Squibb's New Drug Application for Mezigdomide in Patients with Relapsed or Refractory Multiple Myeloma

The Blueprint for Better Lung Cancer Screening

The Conversation (0)